Follow
Lorenzo Muraglia
Lorenzo Muraglia
Nuclear Medicine Division, Humanitas Research Hospital IRCCS, Rozzano, Milan
Verified email at cancercenter.humanitas.it
Title
Cited by
Cited by
Year
Metastatic sites’ Location and impact on patient management after the introduction of prostate-specific membrane antigen positron emission tomography in newly diagnosed and …
F Mattana, L Muraglia, P Rajwa, F Zattoni, G Marra, PKF Chiu, ...
European Urology Oncology 6 (2), 128-136, 2023
112023
First live-experience session with PET/CT specimen imager: a pilot analysis in prostate cancer and neuroendocrine tumor
L Muraglia, F Mattana, LL Travaini, G Musi, E Bertani, G Renne, E Pisa, ...
Biomedicines 11 (2), 645, 2023
72023
Clinical application of cardiac scintigraphy with bone tracers: Controversies and pitfalls in cardiac amyloidosis
F Mattana, L Muraglia, F Girardi, I Cerio, A Porcari, F Dore, R Bonfiglioli, ...
Vessel Plus 6 (13), 2574-1209.2021, 2022
72022
Prostate-Specific Membrane Antigen-Targeted Therapy in Prostate Cancer: History, Combination Therapies, Trials, and Future Perspective
F Mattana, L Muraglia, A Barone, M Colandrea, Y Saker Diffalah, ...
Cancers 16 (9), 1643, 2024
22024
First in human validation of innovative beta radio guided surgery technique in prostate cancer
F Collamati, R Mirabelli, L Muraglia, S Luzzago, S Morganti, FA Mistretta, ...
Journal of Nuclear Medicine 64 (supplement 1), P1481-P1481, 2023
12023
Prostate-specific membrane antigen (PSMA) radioguided surgery in prostate cancer: An overview of current application and future perspectives
L Muraglia, F Mattana, G Zuccotti, F Collamati, S Luzzago, LL Travaini, ...
Clinical and Translational Imaging 11 (3), 255-261, 2023
12023
First live-experience session with PET/CT specimen imager: a pilot analysis in prostate cancer and neuroendocrine tumor. Biomedicines. 2023; 11: 645
L Muraglia, F Mattana, LL Travaini, G Musi, E Bertani, G Renne, E Pisa, ...
12023
Prostate cancer: nuclear medicine imaging in the biochemical recurrence and in oligometastatic disease
L Muraglia, E Lopci, J Jandric, R Zanca, M Rodari, M Perrino, R Lucchini, ...
The quarterly journal of nuclear medicine and molecular imaging: official …, 2024
2024
PD19-12 THE ROLE OF PSMA PET/CT IN PREDICTING PATHOLOGICAL LOCAL STAGING AND GRADING FOR PROSTATE CANCER
A Piccolini, G Chiarelli, P Arena, V Fasulo, F Dagnino, N Frego, P Casale, ...
The Journal of Urology 211 (5S), e445, 2024
2024
PSMA PET/CT and nodal staging in prostate cancer: Comparison between the diagnostic accuracy of different PSMA-ligand radiopharmaceuticals. A single institutional analysis
P Arena, V Fasulo, F Dagnino, A Piccolini, G Chiarelli, N Frego, D Maffei, ...
European Urology 85, S1290, 2024
2024
Toward a framework integrating augmented reality and virtual fixtures for safer robot-assisted lymphadenectomy
Z Chen, K Fan, L Cruciani, M Fontana, L Muraglia, F Ceci, L Travaini, ...
Toward a framework integrating augmented reality and virtual fixtures for …, 2024
2024
FIRST LIVE-EXPERIENCE SESSION WITH PET/CT SPECIMEN IMAGER: A PILOT ANALYSIS IN PROSTATE CANCER AND NEUROENDOCRINE TUMOR
M Ferrari, F Botta, L Muraglia, F Mattana, LL Travaini, G Musi, E Bertani, ...
Physica Medica 115, 102727, 2023
2023
RADIO-GUIDED SURGERY WITH DROP-IN BETA PROBE FOR 68GA-PSMA, IN HIGH-RISK PROSTATE CANCER PATIENTS ELIGIBLE FOR ROBOTIC-ASSISTED RADICAL PROSTATECTOMY
FA Mistretta, S Luzzago, ML Piccinelli, M Ferro, D Bottero, G Cordima, ...
ANTICANCER RESEARCH 43 (10), 4756-4756, 2023
2023
PO-1510 PSMA-PET and PCa: an exploratory analysis beyond the numerical definition of oligometastatic state
MG Vincini, G Corrao, M Zaffaroni, C Lorubbio, F Mastroleo, L Muraglia, ...
Radiotherapy and Oncology 182, S1228-S1229, 2023
2023
PO-1506 FIRST BRC AFTER RP: choline/PSMA-PET or mpMRI guided-SBRT on DETECTABLE PROSTATE BED RECURRENCE
R Santamaria, L Colombi, G Corrao, M Zaffaroni, MG Vincini, D Zerini, ...
Radiotherapy and Oncology 182, S1224-S1225, 2023
2023
[18F]FDG PET/CT: Lung Nodule Evaluation in Patients Affected by Renal Cell Carcinoma
LS Airò Farulla, LL Travaini, M Cuomo, D Galetta, F Mattana, S Frassoni, ...
Tomography 9 (1), 387-397, 2023
2023
[18F]FDG PET/CT: Lung Nodule Evaluation in Patients Affected by Renal Cell Carcinoma.
AF LS, LL Travaini, M Cuomo, D Galetta, F Mattana, S Frassoni, ...
Tomography (Ann Arbor, Mich.) 9 (1), 387-397, 2023
2023
Radio-guided surgery with DROP-IN beta probe for 68Ga-PSMA, in high-risk prostate cancer patients eligible for robotic-assisted radical prostatectomy
F Ceci, F Collamati, S Luzzago, FA Mistretta, L Muraglia, G Renne, ...
European Urology 83, S1295, 2023
2023
Detection of oligometastatic disease by Ga-68-PSMA PET/CT in intermediate to high-risk Prostate Cancer: preliminary data from a multi-centric, retrospective study
F Mattana, L Grappeja, G Zuccotti, A Barone, P Artioli, L Muraglia, R Mei, ...
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING 49 (SUPPL 1 …, 2022
2022
Ten-year follow-up of cardiac resynchronization therapy patients with non-ischemic dilated cardiomyopathy assessed by radionuclide angiography: a single-center cohort study
C Valzania, G Massaro, A Spadotto, L Muraglia, J Frisoni, C Martignani, ...
Journal of Interventional Cardiac Electrophysiology 64 (3), 723-731, 2022
2022
The system can't perform the operation now. Try again later.
Articles 1–20